Please login to the form below

Not currently logged in
Email:
Password:

Launch excellence: beyond the six-month mantra

Ed_Corbett

While the first six months are important, the prior 36 months are even more so.

Digital applications are transforming the market access landscape

Optimising product value through digital technology

Key considerations for disease- modifying Parkinson’s disease trials

‘Lessons learnt from Alzheimer’s trials could help in Parkinson’s drug development’

Shoring up the framework

buildingsEuropean regulators add a measure of clarity to pharma’s uncertainty around Brexit

Japanese pharma pulls no punches with post-Brexit UK

Japan_BrexitFirm want reassurance from the UK on its future in science and innovation

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics